These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

750 related articles for article (PubMed ID: 6357823)

  • 1. Myocardial infarction in women.
    Johansson S; Vedin A; Wilhelmsson C
    Epidemiol Rev; 1983; 5():67-95. PubMed ID: 6357823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progestogens in cardiovascular diseases: an introduction to the epidemiologic data.
    Mann JI
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):752-7. PubMed ID: 7065056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
    LaRosa JC
    Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptive use and myocardial infarction.
    Petitti DB; Sidney S; Quesenberry CP
    Contraception; 1998 Mar; 57(3):143-55. PubMed ID: 9617531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the epidemiology of oral contraceptives and disease.
    Prentice RL; Thomas DB
    Adv Cancer Res; 1987; 49():285-401. PubMed ID: 3314396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.
    Schwingl PJ; Ory HW; Visness CM
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):241-9. PubMed ID: 9914611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contraceptive Steroids, age, and the cardiovascular system.
    Plunkett ER
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):747-51. PubMed ID: 7065055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol, lipoproteins, and coronary heart disease in women.
    Bush TL; Fried LP; Barrett-Connor E
    Clin Chem; 1988; 34(8B):B60-70. PubMed ID: 3042201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of estrogens and progestogens on lipid metabolism.
    Oster P; Arab L; Kohlmeier M; Mordasini R; Schellenberg B; Schlierf G
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):773-5. PubMed ID: 7065057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
    Lidegaard O
    BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives and vascular disease.
    Sartwell PE; Stolley PD
    Epidemiol Rev; 1982; 4():95-109. PubMed ID: 6754411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of correlation between oral contraceptive usage and cardiovascular mortality.
    Wiseman RA
    Int J Fertil; 1984; 29(4):198-208. PubMed ID: 6152441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex hormones and cardiovascular risk.
    La Vecchia C
    Hum Reprod; 1992 Feb; 7(2):162-7. PubMed ID: 1577926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for coronary heart disease in women.
    Hennekens CH
    Cardiol Clin; 1998 Feb; 16(1):1-8. PubMed ID: 9507775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of oral contraceptives and cardiovascular disease.
    Chasan-Taber L; Stampfer MJ
    Ann Intern Med; 1998 Mar; 128(6):467-77. PubMed ID: 9499331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of oral contraceptives and serum beta-carotene.
    Berg G; Kohlmeier L; Brenner H
    Eur J Clin Nutr; 1997 Mar; 51(3):181-7. PubMed ID: 9076409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An epidemiologic survey of cardiovascular disease in women taking oral contraceptives.
    Thorogood M; Vessey MP
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):274-81. PubMed ID: 2196799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two problems in oral contraception: arteriosclerotic cardiopathy and drug interactions.
    Onnis A; Grella PV; Di Lenardo L
    Clin Exp Obstet Gynecol; 1982; 9(2):61-5. PubMed ID: 7160061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.